Skip to content

Postoperative Analgesic Requirements for the ProSeal Laryngeal Mask Airway Versus the Tracheal Tube in Females Undergoing Gynecological Laparoscopic Surgery

Postoperative Analgesic Requirements for the ProSeal Laryngeal Mask Airway Versus the Tracheal Tube in Females Undergoing Gynecological Laparoscopic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00402870
Enrollment
100
Registered
2006-11-22
Start date
2007-08-31
Completion date
2007-09-30
Last updated
2007-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation

Brief summary

The ProSeal laryngeal mask airway is a relatively new airway device with a modified cuff to increase the seal and a drain tube to provide a channel for regurgitated fluid, prevention of gastric insufflation and insertion of a gastric tube. In the following randomized prospective double-blind trial, we test the hypothesis that the postoperative analgesic requirements is higher for the ProSeal laryngeal mask airway than the tracheal tube.

Interventions

ProSeal LMA vs Tracheal Tube

DEVICEProSeal LMA, Tracheal Tube

ProSeal LMA vs Tracheal Tube

Sponsors

Medical University Innsbruck
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * ASA I-II * Age 18-75 * Elective laparoscopic surgery

Exclusion criteria

* Known or predicted difficult airway * Oropharyngeal pathology * Mouth opening \< 3.0 cm * A body mass index \> 35 kg m-2 * Increased risk of aspiration * Inability to communicate or understand the visual analogue scale * Analgesics within 24 hours of surgery

Design outcomes

Primary

MeasureTime frame
Postoperative analgesia24 hrs

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026